Evie Ring
Commercial- Indications
- Women's health monitoring
Company intelligence / Profile preview
Movano Health has developed the Evie Ring, a smart ring designed specifically for women that provides continuous tracking of activity, sleep, heart rate, SpO2, menstrual cycle data and more. Clinical studies have shown the device’s pulse oximeter exceeds FDA accuracy standards across all skin tones. The company submitted updated clinical trial results to the FDA in May 2024 seeking 510(k) clearance as a medical device. The company is also developing non-invasive blood pressure and glucose monitoring sensors currently undergoing clinical studies. As of June 2025 no final FDA clearance has been announced.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Movano Health.